Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure
Wilson JR
and
N Ferraro
The maximal aerobic exercise capacity of patients with chronic heart failure is frequently decreased because of inadequate blood flow to working skeletal muscle. To investigate whether this reduced flow is in part due to interference by angiotensin II with arteriolar dilation in working muscle, the effect of the angiotensin-converting enzyme inhibitor captopril on leg blood flow, leg vascular resistance, leg oxygen consumption (VO2) and leg lactate release during maximal upright bicycle exercise was examined in 12 patients with heart failure (maximal VO2 10.7 +/- 3.1 ml/min per kg). Captopril decreased leg resistance at rest (258 +/- 115 to 173 +/- 67 U, p less than 0.01) and maximal exercise (68 +/- 69 to 45 +/- 29 U, p less than 0.01) associated with proportionately similar decreases in systemic vascular resistance. However, maximal exercise duration and maximal VO2 were unchanged and, at identical peak exercise work times, there was no improvement in leg blood flow (2.0 +/- 0.9 to 2.0 +/- 1.1 liters/min, p = NS), leg VO2 (261 +/- 104 to 281 +/- 157 ml/min, p = NS) or leg lactate release (269 +/- 149 to 227 +/- 151 mg/min, p = NS). These data suggest that, during exercise in patients with heart failure, angiotensin II does not interfere with blood flow to working skeletal muscle.
This article has been cited by other articles:
|
|
|
|
 
I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan
Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention
Circulation,
March 4, 2003;
107(8):
1210 - 1225.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C. Lang, D. B. Chomsky, J. Butler, S. Kapoor, and J. R. Wilson
Prostaglandin production contributes to exercise-induced vasodilation in heart failure
J Appl Physiol,
December 1, 1997;
83(6):
1933 - 1940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Guazzi, G. Marenzi, M. Alimento, M. Contini, and P. Agostoni
Improvement of Alveolar–Capillary Membrane Diffusing Capacity With Enalapril in Chronic Heart Failure and Counteracting Effect of Aspirin
Circulation,
April 1, 1997;
95(7):
1930 - 1936.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. R. Wilson
Exercise Intolerance in Heart Failure : Importance of Skeletal Muscle
Circulation,
January 15, 1995;
91(2):
559 - 561.
[Full Text]
|
|
|
|
|
|
|
J. Myers and V. F. Froelicher
Hemodynamic Determinants of Exercise Capacity in Chronic Heart Failure
Ann Intern Med,
September 1, 1991;
115(5):
377 - 386.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. W. Neuberg, S. H. Friedman, M. B. Weiss, and M. V. Herman
Cardiopulmonary Exercise Testing: The Clinical Value of Gas Exchange Data
Arch Intern Med,
October 1, 1988;
148(10):
2221 - 2226.
[Abstract]
[PDF]
|
|
|
|
